Cytonus Therapeutics
company
About
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $300K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cytonus Therapeutics is a biotech company combining AI-driven drug discovery with a Cargocyte, a synthetic biology approach towards drug-delivery. Cytonus is on a mission to treat immune related disorders with precision delivery and in vivo production of first in class therapeutics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$1.47M
Cytonus Therapeutics has raised a total of
$1.47M
in funding over 2 rounds. Their latest funding was raised on
Jul 1, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2021 | Grant | $300K | 1 | — | — | Detail |
| Mar 1, 2021 | Grant | $450K | 1 | — | — | Detail |
| Nov 1, 2020 | Grant | $400K | 1 | — | — | Detail |
| Oct 1, 2020 | Grant | — | 1 | — | — | Detail |
| Apr 1, 2020 | Grant | $325K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Cytonus Therapeutics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
